Clinical Usefulness Of A Low Dosage Of Intravenous Levetiracetam In Various Types And Causes Of Status Epilepticus: Retrospective Study In A Single Center

Background: Intravenous levetiracetam (LEV) in a moderate to high dosage (>1000mg) is one of the treatment options for status epilepticus (SE). However, its clinical usefulness in a low dosage (500mg) in various types and cause of SE is still unknown.